Your browser doesn't support javascript.
loading
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.
Kishan, Amar U; Wang, Xiaoyan; Sun, Yilun; Romero, Tahmineh; Michalski, Jeff M; Ma, Ting Martin; Feng, Felix Y; Sandler, Howard M; Bolla, Michel; Maingon, Philippe; De Reijke, Theo; Neven, Anouk; Steigler, Allison; Denham, James W; Joseph, David; Nabid, Abdenour; Carrier, Nathalie; Souhami, Luis; Sydes, Matt R; Dearnaley, David P; Syndikus, Isabel; Tree, Alison C; Incrocci, Luca; Heemsbergen, Wilma D; Pos, Floris J; Zapatero, Almudena; Efstathiou, Jason A; Guerrero, Araceli; Alvarez, Ana; San-Segundo, Carmen Gonzalez; Maldonado, Xavier; Xiang, Michael; Rettig, Matthew B; Reiter, Robert E; Zaorsky, Nicholas G; Ong, Wee Loon; Dess, Robert T; Steinberg, Michael L; Nickols, Nicholas G; Roy, Soumyajit; Garcia, Jorge A; Spratt, Daniel E.
Afiliação
  • Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu.
  • Wang X; Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA, USA.
  • Sun Y; Department of Population Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Romero T; Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA, USA.
  • Michalski JM; Department of Radiation Oncology, Washington University, St. Louis, MO, USA.
  • Ma TM; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Feng FY; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Sandler HM; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Bolla M; Radiotherapy Department, University Hospital, Grenoble, France.
  • Maingon P; Department of Oncology, Hematology, and Supportive Care, Sorbonne University, Paris, France.
  • De Reijke T; Department of Urology, Prostate Cancer Network in the Netherlands, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Neven A; Statistics Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Competence Center for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
  • Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
  • Joseph D; Department of Medicine and Surgery, University of Western Australia, Perth, WA, Australia.
  • Nabid A; Department of Radiation Oncology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
  • Carrier N; Clinical Research Center, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
  • Souhami L; Department of Radiation Oncology, McGill University Health Centre, Montréal, QC, Canada.
  • Sydes MR; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Dearnaley DP; The Institute of Cancer Research, London, UK.
  • Syndikus I; Clatterbridge Cancer Centre, Birkenhead, UK.
  • Tree AC; The Institute of Cancer Research, London, UK.
  • Incrocci L; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Heemsbergen WD; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Pos FJ; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Zapatero A; Hospital Universitario de la Princesa, Madrid, Spain.
  • Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Guerrero A; Hospital Son Espases, Palma de Mallorca, Spain.
  • Alvarez A; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • San-Segundo CG; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Maldonado X; Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Xiang M; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Rettig MB; Department of Medical Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Reiter RE; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA.
  • Zaorsky NG; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Ong WL; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
  • Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Roy S; Department of Radiation Oncology, Rush University, Chicago, IL, USA.
  • Garcia JA; Division of Oncology, Seidman Cancer Center, Cleveland, OH, USA.
  • Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Eur Urol ; 82(1): 106-114, 2022 07.
Article em En | MEDLINE | ID: mdl-35469702

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_prostate_cancer Assunto principal: Neoplasias da Próstata / Radioterapia / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_prostate_cancer Assunto principal: Neoplasias da Próstata / Radioterapia / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2022 Tipo de documento: Article
...